Top Midday Gainers

Like
Comment
Favorite

Top Midday Gainers

MT Newswires Live01:51

Travelers' (TRV) Q2 earnings unexpectedly increased year over year, while the property and casualty insurer's written premiums came in ahead of market estimates.

Shares jumped 8.3% as intraday trading volume climbed to over 2.38 million from a daily average of about 1.70 million.

Kalaris Therapeutics (KLRS) said Friday that additional patients from its phase 1a trial of TH103 in neovascular age-related macular degeneration showed improvements in vision and retinal anatomy.

Shares surged 18% as intraday trading volume jumped to over 9.83 million from a daily average of about 79,000.

Callan JMB's (CJMB) shares rose 40% amid heavy trading after the company announced a partnership with Alabama State University to support the development of an integrated pharmaceutical manufacturing ecosystem.

More than 41.8 million shares of the company traded intraday, compared with a daily average of about 373,000.

Price: 365.63, Change: +27.81, Percent Change: +8.23

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2652282784?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-18 01:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2652282784","market":"sh","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> Travelers' (TRV) Q2 earnings unexpectedly increased year over year, while the property and casualty insurer's written premiums came in ahead of market estimates.</p><p>Shares jumped 8.3% as intraday trading volume climbed to over 2.38 million from a daily average of about 1.70 million.</p><p>Kalaris <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (KLRS) said Friday that additional patients from its phase 1a trial of TH103 in neovascular age-related macular degeneration showed improvements in vision and retinal anatomy.</p><p>Shares surged 18% as intraday trading volume jumped to over 9.83 million from a daily average of about 79,000.</p><p><a href=\"https://laohu8.com/S/CJMB\">Callan JMB</a>'s (CJMB) shares rose 40% amid heavy trading after the company announced a partnership with Alabama State University to support the development of an integrated pharmaceutical manufacturing ecosystem.</p><p>More than 41.8 million shares of the company traded intraday, compared with a daily average of about 373,000.</p><p>Price: 365.63, Change: +27.81, Percent Change: +8.23</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-18 01:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Travelers' (TRV) Q2 earnings unexpectedly increased year over year, while the property and casualty insurer's written premiums came in ahead of market estimates.</p><p>Shares jumped 8.3% as intraday trading volume climbed to over 2.38 million from a daily average of about 1.70 million.</p><p>Kalaris <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (KLRS) said Friday that additional patients from its phase 1a trial of TH103 in neovascular age-related macular degeneration showed improvements in vision and retinal anatomy.</p><p>Shares surged 18% as intraday trading volume jumped to over 9.83 million from a daily average of about 79,000.</p><p><a href=\"https://laohu8.com/S/CJMB\">Callan JMB</a>'s (CJMB) shares rose 40% amid heavy trading after the company announced a partnership with Alabama State University to support the development of an integrated pharmaceutical manufacturing ecosystem.</p><p>More than 41.8 million shares of the company traded intraday, compared with a daily average of about 373,000.</p><p>Price: 365.63, Change: +27.81, Percent Change: +8.23</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4533","symbol_name":"AQR资本管理(全球第二大对冲基金)","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2652282784","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2652282784","pubTimestamp":1784310676,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Travelers'  Q2 earnings unexpectedly increased year over year, while the property and casualty insurer's written premiums came in ahead of market estimates.Shares jumped 8.3% as intraday trading volume climbed to over 2.38 million from a daily average of about 1.70 million.Kalaris Therapeutics  said Friday that additional patients from its phase 1a trial of TH103 in neovascular age-related macular degeneration showed improvements in vision and retinal anatomy.Shares surged 18% as intraday trading volume jumped to over 9.83 million from a daily average of about 79,000.Callan JMB's  shares rose 40% amid heavy trading after the company announced a partnership with Alabama State University to support the development of an integrated pharmaceutical manufacturing ecosystem.More than 41.8 million shares of the company traded intraday, compared with a daily average of about 373,000.Price: 365.63, Change: +27.81, Percent Change: +8.23","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","BK4107":"财产与意外伤害保险","KBWP":"Invesco KBW Property & Casualty Insurance ETF","IAK":"iShares Dow Jones U.S. Insurance","BK4588":"碎股","TRV":"旅行者财产险集团","CJMB":"Callan JMB Inc.","BK4585":"ETF&股票定投概念","BK4131":"航空货运与物流","BK4139":"生物科技","KLRS":"Kalaris Therapeutics Inc."},"translate_title":"午盘涨幅最大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CJMB":1,"IAK":0.6,"TRV":1,"KLRS":1,"KBWP":0.6},"content_text":"Travelers' (TRV) Q2 earnings unexpectedly increased year over year, while the property and casualty insurer's written premiums came in ahead of market estimates.Shares jumped 8.3% as intraday trading volume climbed to over 2.38 million from a daily average of about 1.70 million.Kalaris Therapeutics (KLRS) said Friday that additional patients from its phase 1a trial of TH103 in neovascular age-related macular degeneration showed improvements in vision and retinal anatomy.Shares surged 18% as intraday trading volume jumped to over 9.83 million from a daily average of about 79,000.Callan JMB's (CJMB) shares rose 40% amid heavy trading after the company announced a partnership with Alabama State University to support the development of an integrated pharmaceutical manufacturing ecosystem.More than 41.8 million shares of the company traded intraday, compared with a daily average of about 373,000.Price: 365.63, Change: +27.81, Percent Change: +8.23","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}